A
AGIO icon

AlphaQuest’s Agios Pharmaceuticals AGIO Stock Holding History

AlphaQuest’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,963
Closed -$326K – 56
2025
Q4 		$326K Buy
11,963
+6,552
+121% +$230K 0.02% 1149
2025
Q3 		$217K Buy
5,411
+4,742
+709% +$178K 0.01% 1364
2025
Q2 		$22.3K Buy
669
+296
+79% +$8.97K ﹤0.01% 1779
2025
Q1 		$10.9K Sell
373
-4,167
-92% -$138K ﹤0.01% 1785
2024
Q4 		$149K Buy
4,540
+2,338
+106% +$110K 0.02% 977
2024
Q3 		$97.8K Buy
2,202
+1,283
+140% +$58.3K 0.01% 1290
2024
Q2 		$39.6K Buy
+919
New +$33.2K 0.01% 1139
2024
Q1 		– Sell
-1,863
Closed -$41.5K – 1637
2023
Q4 		$41.5K Buy
+1,863
New +$41.7K 0.01% 899

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

AlphaQuest's AGIO Position: Q1 2026 in Review

AlphaQuest sold out of Agios Pharmaceuticals (AGIO) in Q1 2026, closing a stake of 11,963 shares — an estimated $326K sold.

AlphaQuest first reported a position in AGIO in Q4 2023 and held it in 8 quarters. The position peaked at $326K in Q4 2025. 234 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

  • AlphaQuest reported no remaining Agios Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 11,963 Agios Pharmaceuticals shares in Q1 2026, an estimated $326K.
  • AlphaQuest first reported a position in Agios Pharmaceuticals in Q4 2023 and held it in 8 quarters.
  • AlphaQuest's Agios Pharmaceuticals position peaked at $326K in Q4 2025.
  • 234 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.